image
Revolution Medicines, Inc. RVMD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 55.13
-3.9 %
$ 9.27 B
Market Cap
-15.06
P/E
INCOME STATEMENT
11.6 M REVENUE
-67.27%
Growth Rates
1Year -67.27%
3Years -35.41%
5Years -10.50%
7Years 0.00%
10Years 0.00%
-487 M OPERATING INCOME
-88.63%
Growth Rates
1Year -88.63%
3Years -63.88%
5Years -64.59%
7Years 0.00%
10Years 0.00%
-436 M NET INCOME
-75.46%
Growth Rates
1Year -75.46%
3Years -59.20%
5Years -59.87%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Revolution Medicines, Inc.
image
Revenue 11.6 M
Cost Of Revenue 411 M
Gross Profit -400 M
Operating Expenses 499 M
Operating Income -487 M
Other Expenses -50.8 M
Net Income -436 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 11.6 35.4 29.4 43.0 50.0 20.2 0
GROSS PROFIT
Cost Of Revenue 411.2 9.7 7.3 132.3 91.8 1.8 1.2
Gross Profit (399.7) 25.7 22.1 (89.3) (41.7) 18.4 (1.2)
OPERATING INCOME
Operating Expenses 498.8 293.7 217.4 153.7 104.2 60.5 31.1
Selling, General and Administrative Expenses 75.6 40.6 30.4 21.4 12.4 9.4 4.5
Research and Development Expenses 423.1 253.1 186.9 132.3 91.8 51.1 26.6
Operating Income (487.2) (258.3) (188.0) (110.7) (54.1) (40.3) (31.1)
PRE-TAX INCOME
Interest Income Expense 0.3 0 12 K 71 K 0.1 0.1 0.1
Total Other Income 47.3 9.2 0.9 2.2 2.1 (1.5) 2 K
Pre-Tax Income (439.9) (249.1) (187.1) (108.5) (52.0) (41.8) (31.1)
NET INCOME
Tax Provision (3.5) (0.4) (7.3) (0.4) (4.4) (1.3) 0.1
Net Income (436.4) (248.7) (179.8) (108.2) (47.7) (41.8) (31.1)
EPS 3.86 3.08 2.47 1.62 0.81 1.15 0.85